On February 6 and 7, 2026, the Meydene Marrakech hosted the 14th edition of the International Thoracic Oncology Colloquium. Organized by GERCAT, this scientific event brought together international experts to discuss major advances in thoracic oncology.
IHU RespirERA affirmed its expertise through the presentations of Professors Paul Hofman and Charles-Hugo Marquette.
Precision Medicine: The Challenge of Biomarkers
Professor Paul Hofman presented the current challenges of predictive biomarkers, which are essential for tailoring treatments to the biological characteristics of each patient. He particularly emphasized the importance of accurate molecular diagnosis to optimize access to targeted therapies. Additionally, he participated in a practical pathology workshop, facilitating the sharing of protocols with international teams in attendance.
Screening: Rigorous Organization for Early Detection
The prevention component, a strategic pillar of the IHU, was led by Professor Charles-Hugo Marquette. He detailed the essential success factors for the deployment of effective lung cancer screening. He stressed the importance of rigorous selection of at-risk populations and structured multidisciplinary follow-up. As an expert, he also contributed to a clinical workshop on the management of pneumothorax.
International Scientific Influence
This 14th edition confirms the importance of cross-border academic collaborations. By exporting its expertise to Marrakech, IHU RespirERA strengthens its mission of global outreach and its commitment to transforming scientific discoveries into concrete public health benefits.
